Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.2700 (1.06%) ($15.1000 - $15.2700) on Wed. Jan. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 49 | Latest Price | $15.2700(1.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(48%) ARKG(47%) ARKK(47%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.03% in a week (0% probabilities). VIXM(-43%) VXX(-31%) UNG(-18%) USO(-15%) UUP(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.49(-70.6%) | Resistance Level | $15.4 | 5 Day Moving Average | $14.68(4.02%) | 10 Day Moving Average | $14.82(3.04%) | 20 Day Moving Average | $15.4(-0.84%) | To recent high | -23.2% | To recent low | 9.1% | Market Cap | $1.135b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |